Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery
Princess Alexandra Eye Pavilion,
Edinburgh
Correspondence to: Dr M Wright, PAEP, Edinburgh EH3 9HA.
Accepted for publication 1 November 1996
AIMS
To compare the relative
anti-inflammatory potency and safety of topical
diclofenac-gentamicin with beta methasone-neomycin following
strabismus surgery.
METHODS
A single centre, single observer,
prospective, randomised, and double masked clinical trial of 25 children undergoing bilateral symmetrical horizontal strabismus surgery
was carried out. One eye received diclofenac-gentamicin and the
contralateral eye received betamethasone-neomycin; both treatments
were instilled four times a day for 4 weeks postoperatively. Ocular
inflammation was assessed at 1 and 4 weeks postoperatively, objectively
by comparison with a photographic chart and subjectively by questionnaire.
RESULTS
There was no statistically significant
difference in the rate of resolution of the inflammatory response
between each group at both visits.
CONCLUSION
Diclofenac appears to be as effective
as betamethasone in controlling postoperative inflammation following
strabismus surgery and may offer a safer alternative to the use of
topical steroids.
© 1997 by British Journal of Ophthalmology
This article has been cited by other articles:
-
Fan, D. S. P., Yu, C. B. O., Chiu, T. Y. H., Wong, C. Y., Ng, J. S. K., Pang, C. P., Lam, D. S. C.
(2003). Ocular-Hypertensive and Anti-inflammatory Response to Rimexolone Therapy in Children. Arch Ophthalmol
121: 1716-1721
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
